Koers Satsuma Pharmaceuticals, Inc.
Aandelen
STSA
US80405P1075
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08-06-23 |
Mic Iwashima
COO | Chief Operating Officer | 46 | 01-01-17 |
Chief Tech/Sci/R&D Officer | 63 | 01-07-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08-06-23 |
Director/Board Member | 64 | 08-06-23 | |
Ken Takanashi
BRD | Director/Board Member | 59 | 01-06-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,73% | 108 mld. | |
+9,59% | 103 mld. | |
+6,58% | 23,48 mld. | |
-12,59% | 21,93 mld. | |
-3,29% | 19,68 mld. | |
-35,36% | 18,37 mld. | |
-13,29% | 16,33 mld. | |
+4,68% | 13,72 mld. | |
+34,25% | 12,15 mld. |